Edited by Paddy Shivanand and Mehran Yazdanian
Over the last few years, significant scientific advances have stimulated drug discovery in the infectious disease space, spurred by increased investment from several global stakeholders and collaborative drug discovery efforts between pharmaceutical industry and academia. We hope that this thematic series in AAPS Open will shed light on the challenges of drug discovery, development, and distribution to effectively address global drug development, with emphasis on technical, clinical, and regulatory challenges encountered in lower resource settings for both communicable and non communicable diseases. We hope to bring you perspectives from experts to highlight the impact of patient circumstances and regulatory environments on product development and eventually access to safe drug products in the context of global health.
